As a key component of the Wnt signaling pathway, ARL4C upregulates the expression of cyclin D1 and c-myc, thereby affecting the EMT of ccRCC cells and promoting ccRCC. This evidence concerns the gene MYC and nonpapillary renal cell carcinoma.